In a recent experiment, a biomodified magnetite nanoparticle was developed using the Mms6 protein and the barnase*barstar high-affinity protein pair to efficiently recognize and target HER2/neu tumor marker on the surface of cancer cells (Kotelnikova et al., 2018). Here, ERBB2 is linked to cancer.